Literature DB >> 3686543

Pathologic effects of chronic administration of hydrochlorothiazide, with and without sodium nitrite, to F344 rats.

W Lijinsky1, M D Reuber.   

Abstract

The diuretic drug hydrochlorothiazide was administered to 24 male and 24 female F344 rats as a mixture of 0.1% in powdered food. A parallel group of the same size was given 0.1% hydrochlorothiazide plus 0.2% sodium nitrite in the food. A third group received 0.2% sodium nitrite in the food and there was a similar group of untreated controls. The treatments were well tolerated and there was no significant life shortening. A majority of the rats given hydrochlorothiazide, with or without nitrite, developed chronic progressive nephropathy, which was more severe in males than in females. Associated with this were diffuse parathyroid hyperplasia in both groups receiving the drug, also more severe in males than in females, and parallel increases in lesions of the blood vessels (mural thrombosis of the heart and polyarteritis). The few adenomas of the parathyroid and tubular cell adenomas of the kidney in rats ingesting hydrochlorothiazide were not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3686543     DOI: 10.1177/074823378700300313

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  10 in total

1.  Antihypertensive therapy: beta-blockers and diuretics-why do physicians not always follow guidelines?

Authors:  F H Messerli
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-04

Review 2.  Carcinogenicity of antihypertensive therapy.

Authors:  Ehud Grossman; Franz H Messerli; Uri Goldbourt
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

3.  Increased risk of renal cell cancer among women using diuretics in the United States.

Authors:  W D Finkle; J K McLaughlin; S A Rasgon; H H Yeoh; J E Low
Journal:  Cancer Causes Control       Date:  1993-11       Impact factor: 2.506

4.  Diuretics may increase risk of renal cell carcinoma.

Authors:  A Mellemgaard; H Møller; J H Olsen
Journal:  Cancer Causes Control       Date:  1992-07       Impact factor: 2.506

5.  Antihypertensive medication use and risk of renal cell carcinoma.

Authors:  Joanne S Colt; Jonathan N Hofmann; Kendra Schwartz; Wong-Ho Chow; Barry I Graubard; Faith Davis; Julie Ruterbusch; Sonja Berndt; Mark P Purdue
Journal:  Cancer Causes Control       Date:  2017-02-21       Impact factor: 2.506

Review 6.  Shared Risk Factors in Cardiovascular Disease and Cancer.

Authors:  Ryan J Koene; Anna E Prizment; Anne Blaes; Suma H Konety
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

7.  Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA).

Authors:  R A Hiatt; K Tolan; C P Quesenberry
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

Review 8.  Antihypertensive therapy and cancer risk.

Authors:  D C Felmeden; G Y Lip
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

9.  Epidemiology of kidney cancer.

Authors:  D Pascual; A Borque
Journal:  Adv Urol       Date:  2008-11-04

10.  The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989.

Authors:  L S Gold; N B Manley; T H Slone; G B Garfinkel; L Rohrbach; B N Ames
Journal:  Environ Health Perspect       Date:  1993-04       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.